BioNTech SE (BNTX) Interest Expenses (2018 - 2025)
BioNTech SE (BNTX) posted Interest Expenses of -$4.9 million for Q4 2025, up 83.4% sequentially from -$29.5 million in Q3 2025, and up 63.69% YoY from -$3.0 million in Q4 2024.
BioNTech SE (BNTX) Interest Expenses (2018 - 2025) Analysis & Trends
BioNTech SE has reported Interest Expenses for 8 years, with the latest figure at -$4.9 million in Q4 2025.
- Quarterly Interest Expenses rose 63.69% year-over-year to -$4.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$77.9 million (down 121.29% YoY) and the FY2025 annual result came in at $78.9 million, up 169.34% from the prior year.
- Interest Expenses grew to -$4.9 million in Q4 2025 per BNTX's latest filing, from -$29.5 million in the prior quarter.
- Over five years, Interest Expenses peaked at $211.8 million in Q2 2021 and troughed at -$162.3 million in Q4 2022.
- A 5-year average of -$9.7 million and a median of -$7.7 million in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2021 and 2022: Interest Expenses jumped 9868.43% in 2021, then sank 2226.11% in 2022.
- Over 5 years, Interest Expenses stood at -$7.0 million in 2021, then tumbled by 2226.11% to -$162.3 million in 2022, then soared by 83.3% to -$27.1 million in 2023, then jumped by 50.34% to -$13.5 million in 2024, then surged by 63.69% to -$4.9 million in 2025.
- According to Business Quant data, Interest Expenses over the past three periods registered -$4.9 million, -$29.5 million, and -$7.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | -81.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.89 Mn |
| Dec 31, 2025 | -4.89 Mn |
| Sep 30, 2025 | -29.46 Mn |
| Sep 30, 2025 | -29.46 Mn |
| Jun 30, 2025 | -7.92 Mn |
| Jun 30, 2025 | -7.92 Mn |
| Mar 31, 2025 | -35.66 Mn |
| Mar 31, 2025 | -35.66 Mn |
| Dec 31, 2024 | -13.46 Mn |
| Dec 31, 2024 | -13.46 Mn |
| Sep 30, 2024 | -8.79 Mn |
| Sep 30, 2024 | -8.79 Mn |
| Jun 30, 2024 | -7.86 Mn |
| Jun 30, 2024 | -7.86 Mn |
| Mar 31, 2024 | -5.11 Mn |
| Mar 31, 2024 | -5.11 Mn |
| Dec 31, 2023 | -27.11 Mn |
| Dec 31, 2023 | -27.11 Mn |
| Sep 30, 2023 | -2.18 Mn |
| Sep 30, 2023 | -2.18 Mn |